BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27639242)

  • 1. Aspergillus vaccines: Hardly worth studying or worthy of hard study?
    Levitz SM
    Med Mycol; 2017 Jan; 55(1):103-108. PubMed ID: 27639242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4
    Diaz-Arevalo D; Kalkum M
    Methods Mol Biol; 2017; 1625():281-293. PubMed ID: 28584997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects of vaccines for invasive aspergillosis.
    Feldmesser M
    Med Mycol; 2005 Nov; 43(7):571-87. PubMed ID: 16396243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a vaccine for invasive aspergillosis.
    Sheppard DC; Edwards JE
    Clin Infect Dis; 2004 Apr; 38(8):1137-8. PubMed ID: 15095220
    [No Abstract]   [Full Text] [Related]  

  • 5. Saccharomyces as a vaccine against systemic aspergillosis: 'the friend of man' a friend again?
    Liu M; Capilla J; Johansen ME; Alvarado D; Martinez M; Chen V; Clemons KV; Stevens DA
    J Med Microbiol; 2011 Oct; 60(Pt 10):1423-1432. PubMed ID: 21825307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing a vaccine against aspergillosis.
    Stevens DA; Clemons KV; Liu M
    Med Mycol; 2011 Apr; 49 Suppl 1():S170-6. PubMed ID: 20608783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoptive transfer of Aspergillus-specific T cells as a novel anti-fungal therapy for hematopoietic stem cell transplant recipients: Progress and challenges.
    Papadopoulou A; Kaloyannidis P; Yannaki E; Cruz CR
    Crit Rev Oncol Hematol; 2016 Feb; 98():62-72. PubMed ID: 26527379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine progress.
    Ito JI; Lyons JM; Diaz-Arevalo D; Hong TB; Kalkum M
    Med Mycol; 2009; 47 Suppl 1():S394-400. PubMed ID: 19247869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat-Killed Yeast as a Pan-Fungal Vaccine.
    Martinez M; Clemons KV; Stevens DA
    Methods Mol Biol; 2017; 1625():23-30. PubMed ID: 28584980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoproteomics of Aspergillus for the development of biomarkers and immunotherapies.
    Kniemeyer O; Ebel F; Krüger T; Bacher P; Scheffold A; Luo T; Strassburger M; Brakhage AA
    Proteomics Clin Appl; 2016 Oct; 10(9-10):910-921. PubMed ID: 27312145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole glucan particles as a vaccine against murine aspergillosis.
    Clemons KV; Danielson ME; Michel KS; Liu M; Ottoson NC; Leonardo SM; Martinez M; Chen V; Antonysamy MA; Stevens DA
    J Med Microbiol; 2014 Dec; 63(Pt 12):1750-1759. PubMed ID: 25288643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ T cells mediate the protective effect of the recombinant Asp f3-based anti-aspergillosis vaccine.
    Diaz-Arevalo D; Bagramyan K; Hong TB; Ito JI; Kalkum M
    Infect Immun; 2011 Jun; 79(6):2257-66. PubMed ID: 21422177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of corticosteroid immunosuppressed mice against invasive pulmonary aspergillosis.
    Ito JI; Lyons JM
    J Infect Dis; 2002 Sep; 186(6):869-71. PubMed ID: 12198627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active immunizations with peptide-DC vaccines and passive transfer with antibodies protect neutropenic mice against disseminated candidiasis.
    Xin H
    Vaccine; 2016 Jan; 34(2):245-251. PubMed ID: 26620842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvants and delivery systems for antifungal vaccines: current state and future developments.
    Portuondo DL; Ferreira LS; Urbaczek AC; Batista-Duharte A; Carlos IZ
    Med Mycol; 2015 Jan; 53(1):69-89. PubMed ID: 25362733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccinate against aspergillosis! A call to arms of the immune system.
    Stevens DA
    Clin Infect Dis; 2004 Apr; 38(8):1131-6. PubMed ID: 15095219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell immunity and vaccines against invasive fungal diseases.
    Ito JI
    Immunol Invest; 2011; 40(7-8):825-38. PubMed ID: 21815776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy in invasive fungal infection--focus on invasive aspergillosis.
    Lehrnbecher T; Kalkum M; Champer J; Tramsen L; Schmidt S; Klingebiel T
    Curr Pharm Des; 2013; 19(20):3689-712. PubMed ID: 23278541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with mannan protects mice against systemic aspergillosis.
    Liu M; Machová E; Neščáková Z; Medovarská I; Clemons KV; Martinez M; Chen V; Bystrický S; Stevens DA
    Med Mycol; 2012 Nov; 50(8):818-28. PubMed ID: 22587733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune sensing of Aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination.
    Bozza S; Clavaud C; Giovannini G; Fontaine T; Beauvais A; Sarfati J; D'Angelo C; Perruccio K; Bonifazi P; Zagarella S; Moretti S; Bistoni F; Latgé JP; Romani L
    J Immunol; 2009 Aug; 183(4):2407-14. PubMed ID: 19625642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.